TY  - GEN
AU  - Molander,Pauliina
AU  - Sipponen,Taina
AU  - Kemppainen,Helena
AU  - Jussila,Airi
AU  - Blomster,Timo
AU  - Koskela,Ritva
AU  - Nissinen,Markku
AU  - Rautiainen,Henna
AU  - Kuisma,Juha
AU  - Kolho,Kaija-Leena
AU  - Färkkilä,Martti
TI  - Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD
SN  - 1876-4479
PY  - 2014///0422
KW  - Adalimumab
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Anti-Inflammatory Agents, Non-Steroidal
KW  - therapeutic use
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - C-Reactive Protein
KW  - metabolism
KW  - Child
KW  - Child, Preschool
KW  - Colitis, Ulcerative
KW  - drug therapy
KW  - Colonoscopy
KW  - Crohn Disease
KW  - Disease-Free Survival
KW  - Drug Therapy, Combination
KW  - Feces
KW  - chemistry
KW  - Female
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Infliximab
KW  - Leukocyte L1 Antigen Complex
KW  - analysis
KW  - Maintenance Chemotherapy
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Severity of Illness Index
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.crohns.2012.10.018
ER  -